About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Phoenix | 8,251 Studies Near You

Clinical TrialsPhoenix

Clinical Trials in Phoenix

Discover 8,251 clinical trials near Phoenix, Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3821-3840 of 8,251 trials

CompletedOsia 2 Pediatric Expansion StudyThe CochlearTM Osia®2 System was cleared by the Food and Drug Administration November 15, 2019 (K191921) for individuals aged 12 years and older who present with conductive or…NCT05000931·Phoenix, Arizona and 6 others TerminatedThe PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5To evaluate the effects of paricalcitol injection on cardiac structure and function over 48 weeks in subjects with Stage 5 Chronic Kidney Disease (CKD) receiving hemodialysis who…NCT00616902·Phoenix, Arizona and 75 others

Find Trials by Condition in Phoenix

Breast Cancerin Phoenix Lung Cancerin Phoenix Prostate Cancerin Phoenix Colorectal Cancerin Phoenix Melanomain Phoenix Leukemiain Phoenix Lymphomain Phoenix Pancreatic Cancerin Phoenix Ovarian Cancerin Phoenix Brain Cancerin Phoenix Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingStudy of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)The primary purpose of this study is to evaluate the safety and durability of single- and repeat administration of AR-14034 Sustained Release (SR) in subjects with neovascular…NCT05769153·Dothan, Alabama and 41 others

RecruitingTesting Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial ChemotherapyThis phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with peripheral T-cell lymphoma…NCT06724237·Birmingham, Alabama and 164 others

CompletedSwitch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDFThis study will evaluate the efficacy of switching from emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) fixed dose combination (FDC) to emtricitabine/tenofovir alafenamide…NCT02121795·Birmingham, Alabama and 77 others

CompletedOpen-label Extension Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Neovascular ("Wet") Age-related Macular Degeneration (AMD)The primary objective is to assess long-term safety and tolerability of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in patients with neovascular AMD.NCT00964795·Birmingham (2 Locations), Alabama and 123 others

RecruitingREmote Virtual Inspiration: Vitality and EnergyREVIVE is a randomized controlled trial designed to evaluate the effects of a remotely delivered seated Tai Chi/Qigong (TCQ) intervention on cardiometabolic health, stress, sleep…NCT07675681·Phoenix, Arizona

TerminatedThe Childhood and Adolescent Migraine Prevention StudyThe purpose of this research study is to test two medicines for migraine prevention in children and adolescents.NCT01581281·Phoenix, Arizona and 34 others

RecruitingDe-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor…NCT04852887·Birmingham, Alabama and 831 others

Terminated221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's DiseaseThe primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical…NCT02484547·Birmingham, Alabama and 179 others

CompletedA Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDsThe study objective of Period 1 (Day 1 to Week 24) is to compare the safety and efficacy of upadacitinib 30 mg once daily (QD) and 15 mg QD versus placebo for the treatment of…NCT02706847·Huntsville, Alabama and 187 others

CompletedCook IVC Filter StudyThis prospective, multicenter, double-arm clinical study further evaluated the safety and effectiveness of Cook's commercially available inferior vena cava (IVC) filters…NCT02046096·Phoenix, Arizona and 27 others

TerminatedProtego DF4 Post Approval RegistryThe purpose of this registry study is to confirm the long-term safety and reliability of the Protego DF4 right ventricular lead.NCT02243696·Gadsden, Alabama and 67 others

CompletedEffects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyThe purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to…NCT06568042·Chandler, Arizona and 75 others

TerminatedA Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).This randomized, double-blind, placebo-controlled, parallel group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild…NCT02670083·Phoenix, Arizona and 195 others

TerminatedStudy of BMS-587101 in Patients With Moderate to Severe PsoriasisThe purpose of this clinical research study is to learn if BMS-587101 is effective on the treatment of Moderate to Severe Psoriasis.NCT00162253·Phoenix, Arizona and 15 others

CompletedClinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot PainThe purpose of this clinical study is to determine the effectiveness of the Erchonia® EVRL™, manufactured by Erchonia Corporation (the Company), in providing prescription home use…NCT05291975·Phoenix, Arizona and 3 others

CompletedStudy to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)The purpose of this study is to determine the effects of different doses of methotrexate (MTX) when taken with adalimumab in subjects with early rheumatoid arthritis (RA).NCT01185301·Huntsville, Alabama and 67 others

CompletedStudy of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung DiseaseThe purpose of this trial is to evaluate the safety and effectiveness of one dose strength of Denufosol compared to placebo in patients with CF and a predicted FEV1 of greater…NCT00625612·Birmingham, Alabama and 105 others

Active not recruitingErlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)This phase III ALCHEMIST trial studies how well erlotinib hydrochloride compared to observation works in treating patients with stage IB-IIIA non-small cell lung cancer that has…NCT02193282·Birmingham, Alabama and 1406 others

PreviousPage 192 of 413Next

in Phoenix

Heart Diseasein Phoenix